Literature DB >> 776749

Hypothalamic-pituitary-gonadal function in men with cirrhosis of the liver.

N A Mowat, C R Edwards, R Fisher, A S McNeilly, J R Green, A M Dawson.   

Abstract

Hypothalamic-pituitary-gonadal function was studied in 37 cirrhotic males, 25 of whom were alcoholic. Irrespective of aetiology, cirrhotic patients had significantly reduced free testosterone concentrations. Despite low free testosterone concentrations and reduced or absent spermatogenesis, basal levels of luteinizing hormone (LH) and follicle stimulating hormone (FSH) were normal in nearly all patients, suggesting impaired function of the hypothalamic-pituitary-gonadal axis. In 14 cirrhotic men, seven of whom had gynaecomastia, the ability of the pituitary to secrete LH and FSH in response to exogenous gonadotrophin releasing-hormone (LH/FSH-RH) was asssessed. A normal LH response to LH/FSH-RH was obtained in patients without gynaecomastia. An exaggerated LH response was found in four of seven with gynaecomastia, suggesting Leydig cell failure. The Leydig cell response to exogenous gonadotrophin in eight consecutive cirrhotic patients was probably abnormal but difficult to interpret as all but one were within conventionally accepted limits of normality. The patients without gynaecomastia gave a normal or minimally exaggerated FSH response to LH/FSH-RH. Six of seven with gynaecomastia gave a markedly exaggerated response suggesting failure of spermatogenesis, and all tested were either azoospermic of oligospermic. The single patient with a normal FSH response had a normal sperm count. The pituitary cells can therefore respond to LH/RSH-RH and the Leydig cells of the testes show some response to exogenous gonadotrophin. Similar abnormalities in hypothalamic-pituitary-gonadal function have recently been described in patients with normal liver function on chronic oestrogen therapy.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 776749      PMCID: PMC1411137          DOI: 10.1136/gut.17.5.345

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  22 in total

1.  Cirrhosis of the liver: a study of alcoholic and nonalcoholic patients in Boston and London.

Authors:  W H SUMMERSKILL; C S DAVIDSON; J H DIBLE; G K MALLORY; S SHERLOCK; M D TURNER; S J WOLFE
Journal:  N Engl J Med       Date:  1960-01-07       Impact factor: 91.245

2.  Editorial: Sex and alcohol.

Authors:  D H Van Thiel; R Lester
Journal:  N Engl J Med       Date:  1974-08-01       Impact factor: 91.245

Review 3.  Oestrogen metabolism in liver disease.

Authors:  H Adlercreutz
Journal:  J Endocrinol       Date:  1970-01       Impact factor: 4.286

4.  Sex-hormone-binding globulin is an oestrogen amplifier.

Authors:  C W Burke; D C Anderson
Journal:  Nature       Date:  1972-11-03       Impact factor: 49.962

5.  Biologically active androgens and oestradiol in men with chronic liver disease.

Authors:  A Galvão-Teles; C W Burke; D C Anderson; J C Marshall; C S Corker; R L Bown; M L Clark
Journal:  Lancet       Date:  1973-01-27       Impact factor: 79.321

6.  Effects of induced hyperthyroidism on steroid metabolism in man.

Authors:  H Ruder; P Corvol; J A Mahoudeau; G T Ross; M B Lipsett
Journal:  J Clin Endocrinol Metab       Date:  1971-09       Impact factor: 5.958

7.  Estrogen-androgen imbalance in hepatic cirrhosis. Studies in 13 male patients.

Authors:  I J Chopra; D Tulchinsky; F L Greenway
Journal:  Ann Intern Med       Date:  1973-08       Impact factor: 25.391

8.  Further studies on the pathophysiology of testicular feminization syndrome.

Authors:  P Mauvais-Jarvis; Q Crepy; J P Bercovici
Journal:  J Clin Endocrinol Metab       Date:  1971-04       Impact factor: 5.958

9.  Declining testicular function with age. Hormonal and clinical correlates.

Authors:  E L Stearns; J A MacDonnell; B J Kaufman; R Padua; T S Lucman; J S Winter; C Faiman
Journal:  Am J Med       Date:  1974-11       Impact factor: 4.965

10.  Stimulation tests of pituitary-Leydig cell function in normal male subjects and hypogonadal men.

Authors:  D C Anderson; J C Marshall; J L Young; T R Fraser
Journal:  Clin Endocrinol (Oxf)       Date:  1972-04       Impact factor: 3.478

View more
  15 in total

1.  Endocrine disturbances in chronic hepatic disease.

Authors: 
Journal:  Br Med J       Date:  1976-11-13

2.  Correlation between liver cirrhosis and benign prostatic hyperplasia: a morphological study.

Authors:  B Frea; S Annoscia; G Stanta; C Lozzi; G Carmignani
Journal:  Urol Res       Date:  1987

Review 3.  Endocrinological and metabolic effects of alcohol.

Authors:  V Marks; J W Wright
Journal:  Proc R Soc Med       Date:  1977-05

4.  Hypogonadism is not related to the etiology of liver cirrhosis.

Authors:  S Kaymakoğlu; A Okten; Y Cakaloğlu; G Boztaş; F Beşişik; C Taşçioğlu; S Yalçin
Journal:  J Gastroenterol       Date:  1995-12       Impact factor: 7.527

5.  Plasma oestrogens in men with chronic liver disease.

Authors:  J R Green; N A Mowat; R A Fisher; D C Anderson
Journal:  Gut       Date:  1976-06       Impact factor: 23.059

6.  Mechanism of hypogonadism in cirrhotic males.

Authors:  G R Green
Journal:  Gut       Date:  1977-10       Impact factor: 23.059

7.  Mechanism of feminization in male patients with non-alcoholic liver cirrhosis: role of sex hormone-binding globulin.

Authors:  Y Maruyama; Y Adachi; N Aoki; Y Suzuki; H Shinohara; T Yamamoto
Journal:  Gastroenterol Jpn       Date:  1991-08

Review 8.  Role of Nutrition and Muscle in Cirrhosis.

Authors:  Ragesh B Thandassery; Aldo J Montano-Loza
Journal:  Curr Treat Options Gastroenterol       Date:  2016-06

9.  Progesterone, prolactin, and gynaecomastia in men with liver disease.

Authors:  M J Farthing; J R Green; C R Edwards; A M Dawson
Journal:  Gut       Date:  1982-04       Impact factor: 23.059

Review 10.  Sarcopenia from mechanism to diagnosis and treatment in liver disease.

Authors:  Srinivasan Dasarathy; Manuela Merli
Journal:  J Hepatol       Date:  2016-08-08       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.